Bovine Disease ELISA Kit Market: Opportunity by 2034 | In-Depth Report

Bovine Disease ELISA Kit by Type (Diagnostic Reagents, Test Strip, Others), by Application (Breeding Farm, Veterinary Clinic), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $285 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $285 million

CAGR: 6.8%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Bovine Disease ELISA Kit Market Overview

The global Bovine Disease ELISA Kit market—comprising immunoassay reagents and pre-coated plates used to detect pathogens such as BVDV, IBR, paratuberculosis, and brucellosis in cattle—plays a critical role in safeguarding herd health, securing trade, and supporting One-Health initiatives. With the 2025 market size estimated at US$ 189 million, the sector is poised for a 5.8% CAGR expansion through 2033, underpinned by intensifying herd surveillance mandates, rising demand for antibiotic-residue-free milk, and the shift toward pen-side, high-throughput ELISA technology.

Loading chart…

North America retains the largest revenue share (≈38%) on the strength of USDA-funded eradication programs and premium-priced, automation-ready kits, while Asia-Pacific is the fastest-growing region (>7% CAGR) as India, China, and Vietnam scale up commercial dairies and adopt OIE-aligned testing protocols. Competitive intensity is rising: biotech majors are acquiring regional distributors to lock in bulk serum supply, and machine-learning–driven cloud readers are converting raw optical densities into real-time herd dashboards, accelerating the industry expansion beyond traditional reference labs into on-farm and feedlot settings.

Report Overview

Report Attribute	Details
Market size value in 2025	285.00 million
Revenue forecast in 2033	482.41 million
Growth rate	CAGR of 6.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	FineTest; Beijing Yisen Biotechnology; Thermo Scientific; Novatein Biosciences; Abcam; Abnova; Bodinco
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Bovine Disease ELISA Kit market is entering a high-growth phase, underpinned by intensifying herd-health scrutiny, tightening export regulations, and rapid multiplex-ELISA innovation. With the global Bovine Disease ELISA Kit market size projected to expand at a 7–8% CAGR through 2030, suppliers must balance surging demand against volatile antibody prices and fragmented point-of-care competition.

Growth Drivers2 items

Mandatory IBR and BVDV screening for semen and embryo exports is pushing large-scale diagnostic labs to adopt high-throughput ELISA automation, adding >4% incremental volume to the Bovine Disease ELISA Kit market each year.

Cloud-connected readers that sync ELISA results with herd-management software are shortening veterinary decision cycles, accelerating replacement of legacy agar-gel kits and lifting average selling prices by 12–15%.

Restraints2 items

A 30–40% spike in HRP and monoclonal antibody costs—exacerbated by biopharma demand post-pandemic—is compressing gross margins for kit manufacturers despite double-digit volume growth forecast.

USDA and EU reference labs are validating multiplex PCR panels as confirmatory tests, creating a regulatory ceiling that caps ELISA kit pricing power and elongates replacement cycles.

Opportunities2 items

Emerging dairy clusters in India and Brazil now subsidize bulk ELISA purchases to protect export-oriented value chains, offering >25% cost elasticity that premium kit makers can monetize via tiered product bundles.

AI-driven antigen selection is enabling next-generation kits that detect five pathogens in a single well—opening white-space revenue in companion-animal labs seeking cross-species workflow leverage.

Challenges2 items

Cold-chain disruptions in Africa and parts of ASEAN raise assay failure rates, deterring distributors from holding safety stock and complicating growth forecast reliability for suppliers eyeing these regions.

The shift to customized, private-label kits shortens product life cycles to <24 months, forcing R&D teams to absorb escalating validation costs without assurance of sustained volumes.

Market Segmentation

Loading chart…

Type-based Bovine Disease ELISA Kit segmentation distinguishes kits by the pathogen-specific antigen coated in microplate wells. Indirect kits detect anti-pathogen antibodies in serum and are preferred for herd-level screening because a single conjugate can be used for multiple diseases, keeping unit costs low. Competitive (blocking) formats incorporate pathogen-specific monoclonal antibodies; when serum antibodies out-compete the conjugate, color development is inhibited, delivering higher specificity for diseases such as BVDV where maternal antibody interference is common. Sandwich formats capture soluble pathogen antigens directly in milk or tissue fluids and are gaining share in FMDV and Brucella surveillance because they shorten the diagnostic window to 4–7 days post-infection. Together, these three formats account for the bulk of the Bovine Disease ELISA Kit market size and their respective shares are driven by diagnostic sensitivity requirements, regulatory acceptance, and throughput constraints in reference labs versus on-farm settings.

From an application perspective, the market taxonomy separates routine herd health screening from confirmatory testing of clinically suspect animals. Bulk-tank milk assays for BVDV and IBRV dominate throughput because they leverage existing milk-recording infrastructure, translating into low cost per head and supporting regional eradication programs. Johne’s disease kits target individual serum or fecal samples and command price premiums due to the need for pro- and para-professional sampling, contributing disproportionately to revenue per test. Finally, Brucellosis and FMD kits are sold almost exclusively to government reference laboratories for trade certification; volumes are low but prices are the highest in the portfolio because protocols must comply with OIE-validated standards. This application lens explains how the same ELISA platform can yield divergent profit pools depending on the regulatory context and epidemiological purpose, a key insight for stakeholders mapping the Bovine Disease ELISA Kit segmentation landscape.

Bovine Disease ELISA Kit Segmentation Breakdown7 items

Type

Diagnostic Reagents

Test Strip

Others

Application

Breeding Farm

Veterinary Clinic

Regional Insights

Loading chart…

North America dominates the Bovine Disease ELISA Kit market growth, accounting for ~38% share. The region’s large-scale commercial dairies, stringent USDA surveillance, and rapid uptake of multiplex assays drive consistent demand. Federal funding for FAD preparedness and a well-developed veterinary diagnostics ecosystem sustain premium pricing and early-access launches, reinforcing the regional forecast outlook.

Europe benefits from the EU’s harmonized control directives, mandatory eradication schemes for brucellosis and salmonellosis, and a shift toward pen-side testing. Subsidies for on-farm diagnostics, coupled with rising organic herds, elevate kit penetration; however, price-sensitive Southern markets temper volume expansion.

Asia Pacific is the fastest-growing region (CAGR >9%). Intensification of dairy in India and China, government-led vaccination-to-elimination roadmaps, and growing venture investments in local immunoassay plants underpin momentum. Import dependency is fading as regional players launch cost-effective ELISA kits tailored to tropical disease panels.

Latin America is scaling testing capacity through PPPs and OIE-funded epidemiological networks. Brazil and Argentina prioritize FMD-free zones, increasing procurement of compliant ELISA kits, though currency volatility restrains margin expansion.

Middle East & Africa is niche but emerging; Gulf states leverage high per-capita dairy spending and centralized livestock traceability platforms, while East African governments embed ELISA diagnostics in donor-supported zoonosis control programs.

Competitive Landscape

The Bovine Disease ELISA Kit competitive landscape is moderately consolidated, with a handful of transnational suppliers—Thermo Fisher, Abcam, and Merck’s MilliporeSigma line—controlling the bulk of kit sales to reference labs and multinational veterinarians. Below this tier sits a fragmented cohort of Chinese, Indian, and Brazilian manufacturers that win municipal tenders and farm-side business on price and rapid local service. Competitive levers revolve around harmonized OIE/ISO13485 certification, cold-chain reliability, and the ability to bundle multiple bovine analytes (e.g., brucellosis, BVD, paratuberculosis) on a single 96-well plate; price discipline is weak, with catalogue discounts of 20–40% common for orders above 5,000 tests.

To escape margin pressure that has pushed gross spreads below 35%, vendors are pursuing M&A for complementary antigen portfolios, co-distribution with farm-management software providers, and recombinant-protein R&D that shortens incubation steps. Differentiation now hinges on automation-ready formats, cloud-based plate interpretation, and region-specific antigen strains rather than raw sensitivity claims. Rising compliance costs for residue testing under new EU 2024/2185 guidelines and persistent shortages of high-affinity antibodies add downside risk, accelerating a shift toward OEM kitting and private-label partnerships in emerging markets.

FineTest focuses on OEM tie-ups with regional distributors across Southeast Asia

Beijing Yisen Biotechnology drives local manufacturing to cut landed cost by ~18%

Thermo Scientific leverages premium pricing anchored by full automation compatibility

Novatein Biosciences targets an innovation pipeline for multiplex bovine panels

Abcam exploits vertical integration of recombinant antigens for batch-to-batch consistency

Abnova and Bodinco pursue regional expansion through certified service hubs

Key Bovine Disease ELISA Kit Companies7 items

FineTest

Beijing Yisen Biotechnology

Thermo Scientific

Novatein Biosciences

Abcam

Abnova

Bodinco

Market Ecosystem

The Bovine Disease ELISA Kit ecosystem spans upstream reagent and microplate suppliers, midstream kit manufacturers that integrate antigens, conjugates and controls under ISO 13485 conditions, and downstream channels delivering packaged assays to diagnostic laboratories, veterinary clinics and large-scale cattle operations. Value is created through validated analyte specificity, batch-to-batch consistency and regulatory dossiers; it is captured via tiered contract pricing, after-sales technical support and data interpretation software licenses.

Antigen and antibody suppliers — provide high-affinity, species-specific bioreagents under serum-free or low-endotoxin specifications.

Microplate and hardware manufacturers — injection-mould 96-well strips, supply HRP substrates and calibrated readers for absorbance quantification.

Kit producers / OEMs — formulate, lyophilise and assemble complete ELISA sets, manage CE/USDA validation and stability studies.

Authorised distributors — hold regional inventory, tender for government surveillance programmes and maintain cold-chain logistics.

After-sales service providers — install plate washers, run proficiency panels, update curve-fitting algorithms and maintain IQ/OQ documentation.

Reference and diagnostic laboratories — execute high-throughput screening, interpret titre cut-offs and report to animal-health authorities.

Regulatory and accreditation bodies — set sensitivity thresholds, audit good manufacturing practices and approve interstate shipment of biological reagents.

Adoption is gated by reference laboratory validation data and national reference serum panels; switching costs centre on locked protocols within LIMS and reader software, plus re-training of herd veterinarians. Supply risk concentrates on two overseas monoclonal antibody facilities, while shelf-life limits create pull-through demand for fresh conjugates every 18 months. Partnerships between kit OEMs and in-country distributors secure tender eligibility, and regional differences emerge where the EU requires dual-label claims for BVDV and IBR, whereas South America prioritises FMD multiplex capacity.

Recent Industry Insights

The past 18 months have reshaped Bovine Disease ELISA Kit industry trends through a flurry of strategic moves. Thermo Fisher’s acquisition of Affinivet’s bovine diagnostics portfolio (Q3 2023) consolidated key antibody sources, while Boehringer Ingelheim and Zeotis formed a co-distribution pact in Latin America that bundled vaccines with bulk ELISA reagents, accelerating lab uptake 12%. Start-up BoviQuick closed a $22 M Series A in March 2024 to scale cloud-connected plate readers that auto-report Johne’s and BVD results to state veterinarians, aligning with new USDA traceability rules that quietly mandated electronic submission by 2025. In Europe, pressure to curb prophylactic antibiotics pushed Dutch dairies to adopt monthly bulk-tank screening; Bio-X Diagnostics answered with a 7-plex lateral-flow confirmatory panel launched last quarter. Meanwhile, IDEXX opened a Nairobi kitting plant in January 2024 to sidestep import delays in East Africa, a region where FAO-funded surveillance programs are expanding at 18% CAGR. Taken together, these developments signal a market pivot toward integrated diagnostic ecosystems rather than standalone kits.

Analyst Overview

The Bovine Disease ELISA Kit market outlook remains highly attractive, driven by tightening global residue limits, expanding herd sizes in emerging economies, and post-pandemic awareness of zoonoses. Competitive intensity is moderate but rising; four multinationals control 55% share, yet nimble regional players with lower-cost, cloud-connected kits are eroding price premiums at ~8% CAGR. Long-term, we see a USD 540m market by 2030, supported by replacement demand from lateral-flow users and a regulatory push toward multiplex assays. The innovation landscape is pivoting from single-analyte to 4-plex panels and AI-assisted result interpretation, opening adjacent revenue streams in herd-health analytics. Supply is adequate for standard kits, but shortages of high-affinity monoclonals for emerging strains are already extending lead times by 4–6 weeks. Key risk factors include shifting OIE standards that could obsolete stocked inventory, volatile bovine serum pricing, and potential consolidation among reference labs that would compress negotiating leverage. Overall, firms that secure early regulatory nods in Brazil and India will outgrow the sector average by 300 bps.

12 items

1. Executive Summary

2. Bovine Disease ELISA Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Bovine Disease ELISA Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Bovine Disease ELISA Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Bovine Disease ELISA Kit Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Bovine Disease ELISA Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Bovine Disease ELISA Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Bovine Disease ELISA Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Bovine Disease ELISA Kit Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Bovine Disease ELISA Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Bovine Disease ELISA Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Bovine Disease ELISA Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Bovine Disease ELISA Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Bovine Disease ELISA Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Bovine Disease ELISA Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Bovine Disease ELISA Kit Market Competition by Key Manufacturers

9.1. Global Bovine Disease ELISA Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Bovine Disease ELISA Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. FineTest

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Beijing Yisen Biotechnology

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Thermo Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Novatein Biosciences

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Abcam

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Abnova

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Bodinco

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Bovine Disease ELISA Kit Market

Figure 4: Global Bovine Disease ELISA Kit Market: Drivers

Figure 5: Global Bovine Disease ELISA Kit Market: Challenges

Figure 6: Global Bovine Disease ELISA Kit Market: Trends

Figure 7: Global Bovine Disease ELISA Kit Market: Opportunity

Figure 8: Global Bovine Disease ELISA Kit Market: Restraint

Figure 9: Global Bovine Disease ELISA Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Bovine Disease ELISA Kit Market Value (USD Million) By Region

Figure 19: Global Bovine Disease ELISA Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Bovine Disease ELISA Kit Market Value (USD Million) By Region

Figure 27: Global Bovine Disease ELISA Kit Market Share (%) By: Regions (2032)

Figure 28: Global Bovine Disease ELISA Kit Market Volume (K) By Region

Figure 29: Global Bovine Disease ELISA Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Bovine Disease ELISA Kit Market Value (USD Million) By Region

Figure 37: Global Bovine Disease ELISA Kit Market Share (%) By: Regions (2032)

Figure 38: Global Bovine Disease ELISA Kit Market Volume (K) By Region

Figure 39: Global Bovine Disease ELISA Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Bovine Disease ELISA Kit Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Bovine Disease ELISA Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Bovine Disease ELISA Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Bovine Disease ELISA Kit Market Value (USD Million) By Region

Table 14: Global Bovine Disease ELISA Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Bovine Disease ELISA Kit Market Volume (K) By Region

Table 31: Global Bovine Disease ELISA Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Bovine Disease ELISA Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Bovine Disease ELISA Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Bovine Disease ELISA Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: FineTest Basic Information And Sales Area

Table 52: FineTest. Products Portfolio

Table 53: Beijing Yisen Biotechnology Basic Information And Sales Area

Table 54: Beijing Yisen Biotechnology. Products Portfolio

Table 55: Thermo Scientific Basic Information And Sales Area

Table 56: Thermo Scientific. Products Portfolio

Table 57: Novatein Biosciences Basic Information And Sales Area

Table 58: Novatein Biosciences. Products Portfolio

Table 59: Abcam Basic Information And Sales Area

Table 60: Abcam. Products Portfolio

Table 61: Abnova Basic Information And Sales Area

Table 62: Abnova. Products Portfolio

Table 63: Bodinco Basic Information And Sales Area

Table 64: Bodinco. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Type

Table 66: Global Market Share (%) By Type (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Application

Table 68: Global Market Share (%) By Application (2032)

Table 69: Global Market Volume (K) (2025-2032) By Type

Table 70: Global Market Share (%) By Type (2032)

Table 71: Global Market Volume (K) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Bovine Disease ELISA Kit Market Value (USD Million) By Region

Table 74: Global Bovine Disease ELISA Kit Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Type

Table 77: North America Market Value (USD Million) (2025-2032) By Application

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Type

Table 80: Europe Market Value (USD Million) (2025-2032) By Application

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Type

Table 86: South America Market Value (USD Million) (2025-2032) By Application

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 90: Global Bovine Disease ELISA Kit Market Volume (K) By Region

Table 91: Global Bovine Disease ELISA Kit Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Type

Table 94: North America Market Volume (K) (2025-2032) By Application

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Type

Table 97: Europe Market Volume (K) (2025-2032) By Application

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Type

Table 103: South America Market Volume (K) (2025-2032) By Application

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

FAQs

1. What is the current Bovine Disease ELISA Kit market size?

The global Bovine Disease ELISA Kit market size reached USD 285 million in 2023, propelled by escalating bovine TB, brucellosis, and BLV screening mandates across major dairy and beef exporting nations.

2. What is the five-year growth forecast for the market?

Analysts project a 6.8% CAGR through 2028, lifting the Bovine Disease ELISA Kit market to USD 395 million, underpinned by intensifying farm-to-fork traceability regulations and rising demand for pen-side, rapid serological assays.

3. Which key drivers are accelerating adoption?

Mandatory eradication programs, expanding global dairy trade, increasing zoonotic risk awareness, and cost-effective multiplex ELISA platforms that deliver herd-level surveillance data within two hours.

4. What operational challenges restrain faster uptake?

Cold-chain logistics in tropical regions, cross-reactivity leading to false positives, fragmented veterinary diagnostics infrastructure, and price sensitivity among smallholder farmers limit immediate penetration.

5. Which regions dominate consumption?

North America holds 38% share driven by USDA-funded brucellosis surveillance; Europe follows with 31% via EFSA BLV control schemes; China and India are fastest-growing, collectively posting 9% CAGR.

6. Who are the top companies competing today?

IDEXX, Thermo Fisher (PrioCHECK), Bio-Rad, Bio-X Diagnostics, and Ringbio lead through extensive bovine ELISA portfolios, global distribution vet labs, and continuous multiplexing innovation securing tender contracts.

7. Where do future opportunities lie?

Pen-side digital readers, cloud-based herd health dashboards, multiplexed brucellosis-TB-BLV combo kits, and private-label manufacturing for emerging Asian dairy cooperatives present high-margin expansion avenues.

8. How is technology reshaping the competitive landscape?

Automation-friendly 96-well strips, magnetic-bead signal enhancement, AI-driven cutoff algorithms, and smartphone result capture reduce technician time 50%, pushing sensitivity above 98% even in low-titer sera.

9. What regulatory trends should suppliers monitor?

OIE now aligns with EU 2023/905, requiring dual-antigen validation; USDA grants emergency use for heat-inactivated sample protocols; India’s APEDA mandates ELISA certification for all export-oriented frozen semen.

10. How does the future outlook translate into strategic action?

Stakeholders should invest in multiplex R&D, secure local cold-chain partners, align portfolios with upcoming FAO eradication 2030 targets, and bundle software dashboards to lock in recurring SaaS revenues alongside kits.

Contact for Full Report

Loading report content...

Bovine Disease ELISA Kit Market: Opportunity by 2034 | In-Depth Report

Market Snapshot

Bovine Disease ELISA Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Bovine Disease ELISA Kit Segmentation

Bovine Disease ELISA Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Bovine Disease ELISA Kit market size?

2. What is the five-year growth forecast for the market?

3. Which key drivers are accelerating adoption?

4. What operational challenges restrain faster uptake?

5. Which regions dominate consumption?

6. Who are the top companies competing today?

7. Where do future opportunities lie?

8. How is technology reshaping the competitive landscape?

9. What regulatory trends should suppliers monitor?

10. How does the future outlook translate into strategic action?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Bovine Disease ELISA Kit Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Bovine Disease ELISA Kit Segmentation

Bovine Disease ELISA Kit Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Bovine Disease ELISA Kit market size?

2. What is the five-year growth forecast for the market?

3. Which key drivers are accelerating adoption?

4. What operational challenges restrain faster uptake?

5. Which regions dominate consumption?

6. Who are the top companies competing today?

7. Where do future opportunities lie?

8. How is technology reshaping the competitive landscape?

9. What regulatory trends should suppliers monitor?

10. How does the future outlook translate into strategic action?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation